Pharmaceuticals: biopharma medicines in development in 2019, by category

Approximately 4,500 medicines were in the preclinical development phase of the drug pipeline in the United States, as of April 2019. Around 1,120 were being developed to treat the many types of cancer.

What is the preclinical phase of drug development?

Once a promising compound has been discovered, further experiments must take place to test all of its potential benefits and side effects. The preclinical stage sees further testing of the compound in laboratories to discover how the drug works and whether it is likely to be safe in humans. Globally, there were more than 8,500 medicines in the preclinical development stage in 2019. Researchers use preclinical testing to decide whether the drug should continue to clinical trials, where it will be tested in humans.

The journey of a drug from laboratory to pharmacy

The number of drugs in the overall research and development pipeline exceeded 16,000 in 2019. The process starts with basic research and ends with final approval and monitoring from the U.S. Food and Drug Administration (FDA) – for cancer drugs, it can take up to 15 years to complete this journey. In 2018, member companies of the trade group PhRMA (Pharmaceutical Research and Manufacturers of America) invested close to 80 billion U.S. dollars worldwide in research and development.

Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

July 2019

Region

United States

Survey time period

as of April 2019

Supplementary notes

* Medicines are defined as single products that are counted exactly once regardless of the number of indications pursued.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.